Victrex PLC (VCT)

Industry Specialty Chemicals

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

646.00p

Buy

648.00p

arrow-down-8.00p (-1.22%)

Prices updated at 12 Dec 2025, 16:35 GMT

Prices minimum 15 mins delay

Prices in GBX

Victrex PLC manufactures and sells high performance polymers and provides PEEK and PAEK polymer solutions. It operates in two segments namely, Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions).

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Basic Materials

Industry

Specialty Chemicals

Chairman

Dr. Dame Vivienne Cox

CEO

Mr. Jakob Oskar Sigurdsson

Most recent earnings

30 Sep 2025

Fiscal year end

30 Sep 2025

Employees

1,131

Head office

Victrex Technology Centre

Thornton Cleveleys

United Kingdom

FY5 4QD

+44 1253897700

cosec@victrex.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Rosalind Catherine Rivaz Non-Executive Director, Senior Independent non-executive director	-
Dr. Dame Vivienne Cox Non-Executive Director, Chairman	-
Mr. Brendan W D Connolly Non-Executive Director	-
Ms. Janet Elizabeth Ashdown Non-Executive Director	-
Ms. Jane Elizabeth Toogood OBE Non-Executive Director	-
Mr. David Thomas Non-Executive Director	-
Ms. Urmi Prasad Richardson Non-Executive Director	-
Mr. Ian Clifford Melling Executive Director, Chief Financial Officer	-
Mr. Jakob Oskar Sigurdsson Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Columbia Threadneedle Investments EMEA APAC	6,008,104
CT UK Equity Income Fund	5,365,478
M&G Investment Management Limited	3,989,026
FIL Investment Services (UK) Ltd	3,930,398
Schroder Investment Management Limited	3,577,214

Director dealings

Date chevron-l-regular chevron-r-regular	Action
08 Jul 2025	Purchase
13 May 2025	Purchase
21 Mar 2025	Purchase
13 Dec 2024	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.